KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6342-6350

  Shaheen, Sharif M ^a   Akita, Hidetaka ^a   Nakamura, Takashi ^a   Takayama, Shota ^b   Futaki, Shiroh ^b   Yamashita, Atsushi ^c   Katoono, Ryo ^c   Yui, Nobuhiko ^c,d   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antigen presentation; Dendritic cells; Non viral vectors; Stearylated KALA; Transfection

Indexed keywords

ANTIGEN PRESENTATION; DENDRITIC CELLS; NONVIRAL VECTORS; STEARYLATED KALA; TRANSFECTION;

ANTIGENS; BIOMOLECULES; CELL CULTURE; CELL MEMBRANES; ENCODING (SYMBOLS); GENE ENCODING; GENE EXPRESSION; GENE TRANSFER; LIPOSOMES; VACCINES; VECTORS;

DNA;

ARGININE; ARGININE DERIVATIVE; DNA; DNA VACCINE; EPITOPE; KALA PEPTIDE; LIPOFECTAMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NANOPARTICLE; OVALBUMIN; PLASMID DNA; POLYCATION; REAGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; CELL NUCLEUS MEMBRANE; DENDRITIC CELL; DEVICE; ENDOSOME; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NANODEVICE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGEN PRESENTATION; CELL LINE; CELL LINE, TUMOR; DENDRITIC CELLS; FLOW CYTOMETRY; GENETIC VECTORS; HISTOCOMPATIBILITY ANTIGENS CLASS I; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NANOPARTICLES; VACCINES, DNA;

TETRA;

EID: 79959900553     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.014     Document Type: Article

References (49)

1. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. PNAS 1998, 95:7556-7561.
2. Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., et al. IFN-γ and lymphocytes prevent primary tumour development and shape tumor immunogenicity. Nature 2001, 410:1107-1111.
3. Doe B., Selby M., Barnett S., Baenziger J., Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. PNAS 1996, 93(16):8578-8583.
4. Mintern J.D., Bedoui S., Davey G.M., Moffat J.M., Doherty P.C., Turner S.J. Transience of MHC class I-restricted antigen presentation after influenza A virus infection. PNAS 2009, 106(16):6724-6729.
5. Banchereuu J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
6. Martin F.B., Gary T.J. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010, 10:787-796.
7. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999, 398:77-80.
8. Liu M.A. DNA vaccines. J Intern Med 2003, 253:402-410.
9. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259:1745-1749.
10. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. PNAS 1993, 90:11478-11482.
11. Prud'homme G.J. DNA vaccination against tumors. J Gene Med 2005, 7:3-17.
12. Laddy D.J., Weiner D.B. From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 2006, 25:99-123.
13. Cui Z. DNA vaccine. Adv Genet 2005, 54:257-289.
14. Okada N., Masunaga Y., Okada Y., Mizuguchi H., Iiyama S., Mori N., et al. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice. Gene Ther 2003 Oct, 10(22):1891-1902.
15. Okada N., Masunaga Y., Okada Y., Iiyama S., Mori N., Tsuda T., et al. Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors. Cancer Gene Ther 2003 May, 10(5):421-431.
16. Gratton P., Yu J., Griffith J.W., Babbitt R.W., Scotland R.S., Hickey R., et al. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 2003, 9:357-362.
17. Kuhnel F., Schulte B., Wirth T., Woller N., Schafers S., Zender L., et al. Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors. J Virol 2004, 78:13743-13754.
18. Young L.S., Searle P.F., Onion D., Mautner V. Viral gene therapy strategies: from basic science to clinical application. J Pathol 2006, 208:299-318.
19. Marenzi S., Adams R.L., Zardo G., Lenti L., Reale A., Caiafa P. Efficiency of expression of transfected genes depends on the cell cycle. Mol Biol Rep 1999, 26:261-267.
20. Mortimer I., Tam P., MacLachlan I., Graham R.W., Saravolac E.G., Joshi P.B. Cationic lipid-mediated transfection of cells in culture requires mitotic activity. Gene Ther 1999, 6:403-411.
21. Tseng W.C., Haselton F.R., Giorgio T.D. Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochem Biophys Acta 1999, 1445:53-64.
22. Wilke M., Fortunati E., Broek Van den M. Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther 1996, 3:1133-1142.
23. Pollard H., Remy J.S., Loussouarn G., Demolombe S., Behr J.P., Escande D. Polyethyleneimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 1998, 273:7507-7511.
24. Hama S., Akita H., Ito R., Mizuguchi H., Hayakawa T., Harashima H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems. Mol Ther 2006, 13(4):786-794.
25. Hama S., Akita H., Iida S., Mizuguchi H., Harashima H. Quantitative and mechanism-based investigation of post-nuclear delivery events between adenovirus and lipoplex. Nucleic Acids Res 2007, 35:1533-1543.
26. Shaheen SM, Akita H, Yamashita A, Katoono R, Yui N, Biju V, et al. Quantitative analysis of condensation/decondensation status of pDNA in the nuclear sub-domains by QD-FRET, Nucleic Acid Res, in press.
27. Kogure K., Moriguchi R., Sasaki K., Ueno M., Futaki S., Harashima H. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. J Control Release 2004, 98(2):317-323.
28. Akita H., Kudo A., Minoura A., Yamaguti M., Khalil I.A., Moriguchi R., et al. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process. Biomaterials 2009, 30(15):2940-2949.
29. Kakudo T., Chaki S., Futaki S., Nakase I., Akaji K., Kawakami T., et al. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 2004, 43(19):5618-5628.
30. Akita H., Kogure K., Moriguchi R., Nakamura Y., Higashi T., Nakamura T., et al. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J Control Release 2010, 143(3):311-317.
31. Wyman T.B., Nicol F., Zelphati O., Scaria P.V., Plank C., Szoka F.C. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 1997, 36:3008-3017.
32. Futaki S., ohashashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., et al. Bioconjug Chem 2001, 12:1005-1011.
33. Masuda T., Akita H., Harashima H. Evaluation of nuclear transfer and transcription of plasmid DNA condensed with protamine by microinjection: the use of a nuclear transfer score. FEBS Lett 2005, 579(10):2143-2148.
34. Yamashita A., Yui N., Ooya T., Kano A., Maruyama A., Akita H., et al. Synthesis of a biocleavable polyrotaxane-plasmid DNA (pDNA) polyplex and its use for the rapid nonviral delivery of pDNA to cell nuclei. Nat Protoc 2006, 1(6):2861-2869.
35. Hudgins R.R., Jarrold M.F. Helix formation in unsolvated alanine-based peptides: helical monomers and helical dimers. J Am Chem Soc 1999, 121:3494-3501.
36. Masuda T., Akita H., Nishio T., Niikura K., Kogure K., Ijiro K., et al. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system. Biomaterials 2008, 29(6):709-723.
37. Karttunen J., Sanderson S., Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc Natl Acad Sci U S A 1992, 89(13):6020-6024.
38. Karttunen J., Shastri N. Measurement of ligand induced activation in single viable T-cells using the lacZ reporter gene. Proc Natl Acad Sci U S A 1991, 88:3972.
39. Shastri N., Gonzalez F. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J Immunol 1993, 150:2724-2736.
40. Homhuan A., Kogure K., Nakamura T., Shastri N., Harashima H. Enhanced antigen presentation and CTL activity by transduction of mature rather, than immature dendritic cells with octaarginine-modified liposomes. J Control Release 2009, 136:79-85.
41. Khalil I.A., Kogure K., Futaki S., Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 2006, 281(6):3544-3551.
42. Li W., Nicol F., Szoka F.C. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Deliv Rev 2004 Apr 23, 56(7):967-985.
43. Nicol F., Nir S., Szoka F.C. Effect of cholesterol and charge on pore formation in bilayer vesicles by a pH-sensitive peptide. Biophys J 1996 Dec, 71(6):3288-3301.
44. Stein B.S., Gowda S.D., Lifson J.D., Penhallow R.C., Bensch K.G., Engleman E.G. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 1987, 49(5):659-668.
45. Segawa H., Kato M., Yamashita T., Taira H. The roles of individual cysteine residues of Sendai virus fusion protein in intracellular transport. J Biochem 1998, 123:1064-1072.
46. Kaneda Y., Morishita R., Dzau V.J. Prevention of Restenosis by gene therapy. Ann N Y Acad Sci 1997, 811:299-310.
47. Matsumoto Y., Itaka K., Yamasoba T., Kataoka K. Intranuclear fluorescence resonance energy transfer analysis of plasmid DNA decondensation from nonviral gene carriers. J Gene Med 2009, 11(7):615-623.
48. Ooya T., Choi H.S., Yamashita A., Yui N., Sugaya Y., Kano A., et al. Biocleavable polyrotaxane-plasmid DNA polyplex for enhanced gene delivery. J Am Chem Soc 2006, 128(12):3852-3853.
49. Diaz V.P., Wolff T., Markovic J., Pallardó F.V., Foyer C.H. A nuclear glutathione cycle within the cell cycle. Biochem J 2010 Sep 28, 431(2):169-178.